{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:51:10Z","timestamp":1775868670809,"version":"3.50.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:00:00Z","timestamp":1729900800000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UG3TR003908"],"award-info":[{"award-number":["UG3TR003908"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"'la Caixa' Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019179","name":"Fundaci\u00f3n La Caixa","doi-asserted-by":"publisher","award":["LCF\/PR\/HR22\/52420002"],"award-info":[{"award-number":["LCF\/PR\/HR22\/52420002"]}],"id":[{"id":"10.13039\/501100019179","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.it.2023.09.005","type":"journal-article","created":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T08:09:23Z","timestamp":1696666163000},"page":"902-916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Interplay between epigenetic and genetic alterations in inborn errors of immunity"],"prefix":"10.1016","volume":"44","author":[{"given":"Javier","family":"Rodr\u00edguez-Ubreva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia L.","family":"Calvillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa R.","family":"Forbes Satter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1400-2440","authenticated-orcid":false,"given":"Esteban","family":"Ballestar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2023.09.005_bb0005","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1007\/s10875-022-01352-z","article-title":"The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity","volume":"42","author":"Bousfiha","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0010","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2009.07669.x","article-title":"Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions","volume":"145","author":"Chapel","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.it.2023.09.005_bb0015","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1542\/peds.47.5.927","article-title":"Primary immunodeficiencies. Report of a World Health Organization Committee","volume":"47","author":"Fudenberg","year":"1971","journal-title":"Pediatrics"},{"key":"10.1016\/j.it.2023.09.005_bb0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev-pathmechdis-031521-024229","article-title":"Common variable immunodeficiency: more pathways than roads to Rome","volume":"18","author":"Peng","year":"2023","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.it.2023.09.005_bb0025","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41423-020-00520-8","article-title":"Beyond monogenetic rare variants: tackling the low rate of genetic diagnoses in predominantly antibody deficiency","volume":"18","author":"Edwards","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0030","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/s41467-022-29450-x","article-title":"Single-cell atlas of common variable immunodeficiency shows germinal center-associated epigenetic dysregulation in B-cell responses","volume":"13","author":"Rodr\u00edguez-Ubreva","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2023.09.005_bb0035","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrg3230","article-title":"Functions of DNA methylation: islands, start sites, gene bodies and beyond","volume":"13","author":"Jones","year":"2012","journal-title":"Nat. Rev. Genet. 13"},{"key":"10.1016\/j.it.2023.09.005_bb0040","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41576-022-00468-7","article-title":"Histone post-translational modifications - cause and consequence of genome function","volume":"23","author":"Mill\u00e1n-Zambrano","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.it.2023.09.005_bb0045","doi-asserted-by":"crossref","first-page":"34287","DOI":"10.1074\/jbc.R113.512517","article-title":"Cross-talk between site-specific transcription factors and DNA methylation states","volume":"288","author":"Blattler","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2023.09.005_bb0050","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.jaci.2018.01.039","article-title":"Loss-of-function nuclear factor \u03baB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans","volume":"142","author":"Tuijnenburg","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0055","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaci.2019.11.051","article-title":"Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations","volume":"146","author":"Lorenzini","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.621503","article-title":"A pathogenic missense variant in NFKB1 causes common variable immunodeficiency due to detrimental protein damage","volume":"12","author":"Fliegauf","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0065","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/cr.2010.161","article-title":"A single NF\u03baB system for both canonical and non-canonical signaling","volume":"21","author":"Shih","year":"2010","journal-title":"Cell Res."},{"key":"10.1016\/j.it.2023.09.005_bb0070","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1146\/annurev.immunol.021908.132641","article-title":"Regulation and function of NF-kappaB transcription factors in the immune system","volume":"27","author":"Vallabhapurapu","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0075","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev-biophys-083012-130338","article-title":"Molecular basis of NF-\u03baB signaling","volume":"42","author":"Napetschnig","year":"2013","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.it.2023.09.005_bb0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.it.2023.09.005_bb0085","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/mco2.104","article-title":"NF-\u03baB signaling in inflammation and cancer","volume":"2","author":"Zhang","year":"2021","journal-title":"MedComm (Beijing)"},{"key":"10.1016\/j.it.2023.09.005_bb0090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/wsbm.1331","article-title":"Signaling via the NF\u03baB system","volume":"8","author":"Mitchell","year":"2016","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"10.1016\/j.it.2023.09.005_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.716469","article-title":"NF-\u03baB: at the borders of autoimmunity and inflammation","volume":"12","author":"Barnabei","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0100","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jaci.2018.06.050","article-title":"Nuclear factor \u03baB mutations in human subjects: The devil is in the details","volume":"142","author":"Fliegauf","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0105","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.3389\/fimmu.2017.01978","article-title":"Human NF-\u03baB1 haploinsufficiency and Epstein-Barr virus-induced disease-molecular mechanisms and consequences","volume":"8","author":"Hoeger","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0110","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ajhg.2015.07.008","article-title":"Haploinsufficiency of the NF-\u03baB1 subunit p50 in common variable immunodeficiency","volume":"97","author":"Fliegauf","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.it.2023.09.005_bb0115","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10875-016-0306-1","article-title":"NF-\u03baB1 haploinsufficiency causing immunodeficiency and EBV-driven lymphoproliferation","volume":"36","author":"Boztug","year":"2016","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0120","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.3389\/fimmu.2019.02618","article-title":"Late-onset antibody deficiency due to monoallelic alterations in NFKB1","volume":"10","author":"Schr\u00f6der","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0125","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41423-019-0202-8","article-title":"Transcriptional and epigenetic regulation of immune tolerance: roles of the NF-\u03baB family members","volume":"16","author":"Zhang","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0130","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1038\/ncomms9266","article-title":"GITR subverts Foxp3(+) Tregs to boost Th9 immunity through regulation of histone acetylation","volume":"6","author":"Xiao","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2023.09.005_bb0135","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jhep.2010.03.025","article-title":"The NF-kappaB p50:p50:HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes","volume":"53","author":"Elsharkawy","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.it.2023.09.005_bb0140","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.immuni.2016.05.013","article-title":"The costimulatory receptor OX40 inhibits interleukin-17 expression through activation of repressive chromatin remodeling pathways","volume":"44","author":"Xiao","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.it.2023.09.005_bb0145","article-title":"Integrated multi-omics analyses of NFKB1 patients B cells points towards an up regulation of NF-\u03baB network inhibitors","author":"Camacho-Ordonez","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.it.2023.09.005_bb0150","doi-asserted-by":"crossref","first-page":"10981","DOI":"10.1093\/nar\/gkac941","article-title":"Vitamin C enhances NF-\u03baB-driven epigenomic reprogramming and boosts the immunogenic properties of dendritic cells","volume":"50","author":"Morante-Palacios","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.it.2023.09.005_bb0155","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/onc.2011.308","article-title":"Phosphorylation of RelA\/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1","volume":"31","author":"Liu","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.it.2023.09.005_bb0160","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1007\/s10875-023-01483-x","article-title":"JAKs and STATs from a clinical perspective: loss-of-function mutations, gain-of-function mutations, and their multidimensional consequences","volume":"43","author":"Ott","year":"2023","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0165","article-title":"Structural and mutational analysis of member-specific STAT functions","volume":"2022","author":"Erdogan","year":"1866","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.it.2023.09.005_bb0170","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/pro.3519","article-title":"The molecular details of cytokine signaling via the JAK\/STAT pathway","volume":"27","author":"Morris","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.it.2023.09.005_bb0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrrheum.2015.167","article-title":"Type I\/II cytokines, JAKs, and new strategies for treating autoimmune diseases","volume":"12","author":"Schwartz","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.it.2023.09.005_bb0180","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMra1202117","article-title":"JAKs and STATs in immunity, immunodeficiency, and cancer","volume":"368","author":"O\u2019Shea","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2023.09.005_bb0185","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.cell.2010.08.023","article-title":"Phosphotyrosine signaling: evolving a new cellular communication system","volume":"142","author":"Lim","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.it.2023.09.005_bb0190","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/43206","article-title":"A family of cytokine-inducible inhibitors of signalling","volume":"387","author":"Starr","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.it.2023.09.005_bb0195","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1101\/gad.955501","article-title":"A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases","volume":"15","author":"Jackson","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.it.2023.09.005_bb0200","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1126\/science.278.5344.1803","article-title":"Specific inhibition of Stat3 signal transduction by PIAS3","volume":"278","author":"Chung","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.it.2023.09.005_bb0205","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.it.2023.09.005_bb0210","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.bj.2021.03.003","article-title":"Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype","volume":"44","author":"Faletti","year":"2021","journal-title":"Biomed. J."},{"key":"10.1016\/j.it.2023.09.005_bb0215","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/eji.201847955","article-title":"Interferon signature in patients with STAT1 gain-of-function mutation is epigenetically determined","volume":"49","author":"Kaleviste","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0220","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1002\/eji.201445344","article-title":"Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC)","volume":"45","author":"Zheng","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0225","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaci.2022.09.002","article-title":"Monogenic early-onset lymphoproliferation and autoimmunity: natural history of STAT3 gain-of-function syndrome","volume":"151","author":"Leiding","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110244","article-title":"Vitamin D receptor, STAT3, and TET2 cooperate to establish tolerogenesis","volume":"38","author":"Catal\u00e0-Moll","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.it.2023.09.005_bb0235","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.4049\/jimmunol.1302778","article-title":"A novel role for histone deacetylase 6 in the regulation of the tolerogenic STAT3\/IL-10 pathway in APCs","volume":"193","author":"Cheng","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0240","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1073\/pnas.0501959102","article-title":"STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes","volume":"102","author":"Zhang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2023.09.005_bb0245","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MOH.0000000000000206","article-title":"Signal transducer and activator of transcription 3: a year in review","volume":"23","author":"Forbes","year":"2016","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.it.2023.09.005_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101106","article-title":"ROR\u03b3t-driven TH17 cell differentiation requires epigenetic control by the Swi\/Snf chromatin remodeling complex","volume":"23","author":"Lee","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.it.2023.09.005_bb0255","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tibs.2022.06.002","article-title":"A NuRD for all seasons","volume":"48","author":"Reid","year":"2023","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.it.2023.09.005_bb0260","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.4049\/jimmunol.1601712","article-title":"Epigenetic component p66a modulates myeloid-derived suppressor cells by modifying STAT3","volume":"198","author":"Xin","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0265","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221755","article-title":"Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease","volume":"220","author":"Sharma","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.09.005_bb0270","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.immuni.2010.06.003","article-title":"Discrete roles of STAT4 and STAT6 transcription factors in tuning epigenetic modifications and transcription during T helper cell differentiation","volume":"32","author":"Wei","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.it.2023.09.005_bb0275","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.immuni.2017.12.010","article-title":"The transcription factor STAT6 mediates direct repression of inflammatory enhancers and limits activation of alternatively polarized macrophages","volume":"48","author":"Czimmerer","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.it.2023.09.005_bb0280","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0092-8674(94)90407-3","article-title":"The Ikaros gene is required for the development of all lymphoid lineages","volume":"79","author":"Georgopoulos","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.it.2023.09.005_bb0285","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1074-7613(00)80034-5","article-title":"Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes","volume":"10","author":"Kim","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.it.2023.09.005_bb0290","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.celrep.2019.06.029","article-title":"MTA2\/NuRD regulates B cell development and cooperates with OCA-B in controlling the Pre-B to immature B cell transition","volume":"28","author":"Lu","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.it.2023.09.005_bb0295","doi-asserted-by":"crossref","first-page":"8823","DOI":"10.1038\/ncomms9823","article-title":"Ikaros mediates gene silencing in T cells through Polycomb repressive complex 2","volume":"6","author":"Oravecz","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2023.09.005_bb0300","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1074\/jbc.M115.679332","article-title":"Transcriptional regulation of JARID1B\/kdm5b histone demethylase by Ikaros, histone deacetylase 1 (HDAC1), and casein kinase 2 (CK2) in B-cell acute lymphoblastic leukemia","volume":"291","author":"Wang","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2023.09.005_bb0305","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1056\/NEJMoa1512234","article-title":"Loss of B cells in patients with heterozygous mutations in IKAROS","volume":"374","author":"Kuehn","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2023.09.005_bb0310","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi7160","article-title":"Gain-of-function IKZF1 variants in humans cause immune dysregulation associated with abnormal T\/B cell late differentiation","volume":"7","author":"Hoshino","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0315","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1182\/blood.2020007292","article-title":"Germline IKAROS dimerization haploinsufficiency causes hematologic cytopenias and malignancies","volume":"137","author":"Kuehn","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.it.2023.09.005_bb0320","article-title":"A novel STAT1 loss-of-function mutation associated with Mendelian susceptibility to mycobacterial disease","volume":"1212","author":"Ye","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.it.2023.09.005_bb0325","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1182\/blood-2010-04-280586","article-title":"A novel form of human STAT1 deficiency impairing early but not late responses to interferons","volume":"116","author":"Kong","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.it.2023.09.005_bb0330","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/intimm\/dxaa043","article-title":"Autosomal recessive complete STAT1 deficiency caused by compound heterozygous intronic mutations","volume":"32","author":"Sakata","year":"2020","journal-title":"Int. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0335","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1100102","article-title":"STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis","volume":"365","author":"van de Veerdonk","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2023.09.005_bb0340","article-title":"Clinical relevance of gain- and loss-of-function germline mutations in STAT1: a systematic Review","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0345","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.jaci.2016.10.033","article-title":"A novel kindred with inherited STAT2 deficiency and severe viral illness","volume":"139","author":"Moens","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0350","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1073\/pnas.1220098110","article-title":"STAT2 deficiency and susceptibility to viral illness in humans","volume":"110","author":"Hambleton","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2023.09.005_bb0355","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20192319","article-title":"Homozygous STAT2 gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy","volume":"217","author":"Gruber","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.09.005_bb0360","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aav7501","article-title":"Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2","volume":"4","author":"Duncan","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0365","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.iac.2018.08.007","article-title":"An update on syndromes with a hyper-IgE phenotype","volume":"39","author":"Bergerson","year":"2019","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"10.1016\/j.it.2023.09.005_bb0370","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jaip.2019.02.018","article-title":"Clinical aspects of STAT3 gain-of-function germline mutations: a systematic review","volume":"7","author":"Fabre","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.it.2023.09.005_bb0375","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/infdis\/jix522","article-title":"Paracoccidioidomycosis associated with a heterozygous STAT4 mutation and impaired IFN-\u03b3 immunity","volume":"216","author":"Schimke","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.it.2023.09.005_bb0380","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa2202318","article-title":"Variant STAT4 and response to ruxolitinib in an autoinflammatory syndrome","volume":"388","author":"Baghdassarian","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2023.09.005_bb0385","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","article-title":"The JAK-STAT pathway: impact on human disease and therapeutic intervention","volume":"66","author":"O\u2019Shea","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.it.2023.09.005_bb0390","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jaci.2019.09.016","article-title":"Human signal transducer and activator of transcription 5b (STAT5b) mutation causes dysregulated human natural killer cell maturation and impaired lytic function","volume":"145","author":"Vargas-Hern\u00e1ndez","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0395","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/s41467-018-04521-0","article-title":"Dominant-negative STAT5B mutations cause growth hormone insensitivity with short stature and mild immune dysregulation","volume":"9","author":"Klammt","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2023.09.005_bb0400","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1182\/blood-2016-09-737817","article-title":"Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea","volume":"129","author":"Ma","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.it.2023.09.005_bb0405","doi-asserted-by":"crossref","first-page":"8470","DOI":"10.1038\/ncomms9470","article-title":"Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in S\u00e9zary syndrome","volume":"6","author":"Kiel","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2023.09.005_bb0410","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41375-018-0342-3","article-title":"Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia","volume":"33","author":"Cross","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.it.2023.09.005_bb0415","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.jaci.2012.03.012","article-title":"STAT6 and LRP1 polymorphisms are associated with food allergen sensitization in Mexican children","volume":"129","author":"Hancock","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0420","doi-asserted-by":"crossref","first-page":"13992","DOI":"10.1038\/ncomms13992","article-title":"Biallelic JAK1 mutations in immunodeficient patient with mycobacterial infection","volume":"7","author":"Eletto","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2023.09.005_bb0425","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.jaci.2016.12.957","article-title":"JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndrome","volume":"139","author":"Del Bel","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0430","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.immuni.2020.07.006","article-title":"Complex autoinflammatory syndrome unveils fundamental principles of JAK1 kinase transcriptional and biochemical function","volume":"53","author":"Gruber","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.it.2023.09.005_bb0435","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nsmb.2099","article-title":"The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling","volume":"18","author":"Ungureanu","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.it.2023.09.005_bb0440","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1182\/blood-2016-02-698951","article-title":"Cooperation of germ line JAK2 mutations E846D and R1063H in hereditary erythrocytosis with megakaryocytic atypia","volume":"128","author":"Kapralova","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.it.2023.09.005_bb0445","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.270.5237.797","article-title":"Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development","volume":"270","author":"Russell","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.it.2023.09.005_bb0450","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/377065a0","article-title":"Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)","volume":"377","author":"Macchi","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.it.2023.09.005_bb0455","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.3389\/fimmu.2017.01824","article-title":"An activating Janus kinase-3 mutation is associated with cytotoxic T lymphocyte antigen-4-dependent immune dysregulation syndrome","volume":"8","author":"Sic","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0460","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2020-142078","article-title":"Germline gain-of-function JAK3 mutation in familial chronic lymphoproliferative disorder of NK cells","volume":"136","author":"Lesmana","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.it.2023.09.005_bb0465","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.immuni.2006.09.009","article-title":"Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity","volume":"25","author":"Minegishi","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.it.2023.09.005_bb0470","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fped.2020.00253","article-title":"A TYK2 gene mutation c.2395G>A leads to TYK2 deficiency: a case report and literature review","volume":"8","author":"Wu","year":"2020","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.it.2023.09.005_bb0475","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau8714","article-title":"Tuberculosis and impaired IL-23-dependent IFN-\u03b3 immunity in humans homozygous for a common TYK2 missense variant","volume":"3","author":"Boisson-Dupuis","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0480","doi-asserted-by":"crossref","DOI":"10.1111\/pai.13671","article-title":"Novel mutations of TYK2 leading to divergent clinical phenotypes","volume":"33","author":"Lv","year":"2022","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.it.2023.09.005_bb0485","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/leu.2016.277","article-title":"Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences","volume":"31","author":"Waanders","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.it.2023.09.005_bb0490","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2023.09.005_bb2005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13059-015-0863-2","article-title":"IL-4 orchestrates STAT6-mediated DNA demethylation leading to dendritic cell differentiation","volume":"17","author":"Vento-Tormo","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.it.2023.09.005_bb2010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-020-00936-x","article-title":"IKAROS-associated diseases in 2020: genotypes, phenotypes, and outcomes in primary immune deficiency\/inborn errors of immunity","volume":"41","author":"Kuehn","year":"2021","journal-title":"J. Clin. Immunol."}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490623001977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490623001977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:12:46Z","timestamp":1761462766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490623001977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":100,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1471490623001977"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2023.09.005","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interplay between epigenetic and genetic alterations in inborn errors of immunity","name":"articletitle","label":"Article Title"},{"value":"Trends in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.it.2023.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}